SCHEMBL1633802

SCHEMBL1633802

CC(=O)Nc1cccc(S(F)(F)(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
HSD17B10 Q99714 2/20 0.58
CYP1A2 P05177 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.56
AKR1C3 P42330 2/20 0.55
AKR1C2 P52895 2/20 0.55
RAB9A P51151 2/20 0.53
POLB P06746 1/20 0.53
NR4A1 P22736 1/20 0.53
NAPRT Q6XQN6 1/20 0.52
PTGS1 P23219 1/20 0.51
PTGS2 P35354 1/20 0.51
TAS2R14 Q9NYV8 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 1/20 0.49
NQO2 P16083 1/20 0.47
MAPT P10636 1/20 0.47
GAA P10253 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21488823 0.85 AKR1C3 (0.58) ALDH1A1AKR1C3AKR1C2RAB9APOLB
SCHEMBL30645447 0.83 AKR1C3 (0.53) ALDH1A1AKR1C3AKR1C2RAB9APTGS1
SCHEMBL1901172 0.80 ALDH1A1 (0.76) ALDH1A1HSD17B10CYP1A2L3MBTL1RAB9A
SCHEMBL21488709 0.79 AKR1C3 (0.53) ALDH1A1AKR1C3AKR1C2RAB9APTGS1
SCHEMBL18607707 0.78 KCNK3 (0.69) AKR1C3AKR1C2RAB9APOLBPTGS1
SCHEMBL16692670 0.78 TGM2 (0.59) AKR1C3AKR1C2PTGS1PTGS2TAS2R14
SCHEMBL8043270 0.77 SMN1; SMN2 (0.59) ALDH1A1HSD17B10L3MBTL1RAB9APOLB
SCHEMBL28430855 0.77 KCNK3 (0.63) ALDH1A1AKR1C3AKR1C2PTGS1PTGS2
SCHEMBL28428977 0.76 TYK2 (0.54) AKR1C3AKR1C2RAB9ASMN1; SMN2KMT2A
SCHEMBL687148 0.76 GAA (0.68) ALDH1A1HSD17B10CYP1A2L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932416-B2 Prepared by electrophilic aromatic substitution via halogenation, chlorosulfonation or nitration of a pentafluorosulfanylbenzene; 2-Methyl-5-nitro-4-pentafluorosulfuranylbenzoic acid; for liquid crystals, polymers, pesticides, herbicides, fungicides, nematocides, parasiticides, insecticides, acaricides SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2011-04-26 US disclosed
US-20080091031-A1 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates SANOFI-AVENTIS DEUTSCHLAND GMBH (FR) 2008-04-17 US disclosed
US-7317124-B2 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-01-08 US disclosed
US-20050148652-A1 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148652-A1 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates PFAS, DDT, PNPO ALDH1A1 793/4885HSD17B10 1589/4885CYP1A2 69/4885
US-20080091031-A1 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates PFAS, DDT, PNPO ALDH1A1 793/4885HSD17B10 1589/4885CYP1A2 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.